Q&As in 2023

Summary: Cultivated or cultured meat is promising to revolutionize the food industry in the coming years to decades, helping to resolve concerns related to the environmental impact and ethical implications linked to conventional meat production. We talked to Dr. Sandhya Sriram, the Group CEO and Co-founder of Shiok Meats Pte. Ltd., Singapore; Prof. Shulamit Levenberg, the former Dean of the Biomedical Engineering Department at the Technion, current Director of the Technion Center for 3D Bioprinting and The Rina & Avner Schneur Center for Diabetes Research, as well as the Co-founder and Chief Scientific Adviser of Aleph Farms, Israel; and Dr. Timothy Olsen, Head of Cultured Meat in the Life Science business at Merck KGaA, Germany; about this relatively new and quickly developing sector. They explain what their teams are working on, including the biggest recent accomplishments, speak about the main challenges facing the field and how they can be resolved, and share their visions about the future of cultivated meat, aiming to provide more equitable and sustainable access to nutritious food for the growing world population.

Medicinal chemistry is a fast-evolving interdisciplinary research area which aims to improve human life by developing drugs to combat diseases. Nature Communications interviewed three scientists, Daniele Castagnolo (Associate Professor at University College London), Paramita Sarkar (postdoctoral researcher at University of Würzburg) and Dani Schulz (Director, Discovery Process Chemistry at Merck), about their careers and the past and future in medicinal chemistry research. We asked the researchers what medicinal chemistry means to them, and their opinions on the current relevance of the Rule of Five and new chemical modalities beyond the Rule of Five. We also discuss the differences between academic and industry research in medicinal chemistry and how Open Science can support collaborations for drug development.

The process of patenting inventions may be complex. Academic researchers whose primary goal is getting their work published in scientific journals often face daunting doubts when it comes to understanding the interplay between publishing and patenting their findings. We asked Prof Frank Tietze questions from the perspective of academic researchers who wish to understand how the patenting process works and—most importantly—the relation between patenting and publishing.

Organizations have been founded to build communities by bringing together scientists from diverse backgrounds but with one shared identity and the common goal of strengthening their roles, increasing their visibility, and promoting their representation. In this conversation, representatives from three such organizations share their experiences and advice with Nature Communications. Priscilla Kolibea Mante (a Co-Chair), Encieh Erfani (a member of the Executive Committee) and Lisa Herzog (an alumna) of the Global Young Academy (GYA) discuss the role of their organization in supporting early career researchers. Kaela Singleton, the president-elect of Black In Neuro, discusses their mission to empower Black neuroscientists. Jennifer Thomson, the president of the Organization for Women in Science for the Developing World (OWSD), informs us about their efforts in providing career development, networking and leadership opportunities to women from the developing (and developed) world.